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Response 
Jay Katz: From Harms to Risks 
Larry I. Palmer, LL.B* 
Jay Katz's towering presence in the scholarship on human experimentation 
has been a source of personal and professional inspiration. As I noted over thirty 
years ago in my review essay about his classic work, Experimentation with 
Human Beings, 1 Jay's scholarship asks tough and penetrating questions about a 
truth we modern professionals hold to be sacred.2 We have always assumed that 
growth in scientific knowledge and social progress are linked. Yet as Alex 
Capron discusses in his paper,3 scientific knowledge has sometimes been 
produced by means we would not consider socially progressive. Jay's analysis of 
the history of experimentation with human beings before, during, and after the 
Nazi era dispels the comforting notion that the Nazi investigators were 
individuals working outside the moral ethos of modern medicine and science 
(i.e., that they were merely racists and sadists). Instead, Jay reveals that they were 
physician-investigators searching aggressively (albeit blindly) for even better 
ways of making science socially useful and relevant.4 
* Endowed Chair in Urban Health Policy, Professor of Family and Geriatric Medicine, and 
Professor of Health Management and Systems Sciences, University of Louisville. 
I. JAY KATZ ET AL., EXPERIMENTATION WITH HUMAN BEINGS: THE AUTHORITY OF THE 
INVESTIGATOR, SUBJECT, PROFESSIONS, AND STATE IN THE HUMAN EXPERIMENTATION PROCESS 
( 1972). 
2. Larry I. Palmer, Commentary, The High Priests Questioned or at Least Cross-Examined, 5 
RUTGERS-CAM. L.J. 237 ( 1973-1974). 
3. Alex Capron, Experimentation with Human Beings: Light or Only Shadows?, 6 YALE J. 
HEALTH POL 'y L. & ETHICS 431 (2006). 
4. See. e.g., Jay Katz, The Consent Principle of the Nuremberg Code: Its Significance Then 
and Now, in THE NAZI DOCTORS AND THE NUREMBERG CODE: HUMAN RIGHTS IN HUMAN 
EXPERIMENTATION 227 (George J. Annas & Michael A. Grodin eds., 1992) (observing that the 
Nuremberg Code's relentless and uncompromising commitment to the psychological integrity of 
research subjects has not been matched either prior to its promulgation or since); Jay Katz, The 
Nuremberg Code and the Nuremberg Trial: A Reappraisal, 276 lAMA 1662, 1663 (1996) (noting 
that, in the history of medical science, harms, including death, have always been associated with 
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In this response, I illustrate Jay's broad influence on the entire field of 
bioethics by beginning with a personal tribute that honors Jay as a scholar and 
teacher. As one of his former students, I can attest that his method of combining 
scholarship and teaching deserves the label "inspirational." Second, I discuss 
how my own scholarship and teaching have been shaped by Jay's courageous 
insistence that to protect human, subjects we must develop new types of 
institutional arrangements.5 Jay used his position on bioethics commissions 
(starting with the panel to review the Tuskegee Study of Untreated Syphilis in the 
Negro Male)6 and his writings to advocate for institutional change of the manner 
in which we regulate research. Finally, I argue that Jay Katz's scholarship and 
career provide a warning to those of us who call ourselves "bioethicists" in what 
I have called the "human genome era."7 Bioethics is now in some senses a new 
"profession," with all of the accompanying risks and benefits of that societal 
recognition. We may need to return to Jay's work to uncover the reflective skills 
for analyzing our own role in promoting, or perhaps impeding, "social progress." 
I. JAY'S INFLUENCE: A PERSONAL REFLECTION 
I was one of approximately thirty students in Jay's Family Law class in the 
spring of 1968. At a certain point in the course, Jay invited Anna Freud to 
participate in our class for several weeks. On those occasions, the classroom was 
also packed with a large number of law school faculty members, including Joe 
Goldstein. 
medical research, but death had not been part of the research design before the Nazi doctors); Jay 
Katz, The Regulation of Human Experimentation in the United States-A Personal Odyssey, 9 IRB: 
REv. OF HUM. SUBJECTS REs. 1, 2 (1987) [hereinafter Katz, Regulation] (arguing that Nazi studies 
had antecedents and recounting some earlier examples of investigators discounting the dignity of 
human beings); Jay Katz, Human Sacrifice and Human Experimentation: Reflections at 
Nuremberg, Address at the Conference Commemorating the Fiftieth Anniversary of the Nazi 
Doctors' Trial at Nuremberg Convened by International Physicians for the Prevention of Nuclear 
War and Physicians for Social Responsibility (Oct. 27, 1996) (transcript available at 
http://www.law.yale.edu/outsidelhtrnl/Publications/pub-katz.htrn) (reviewing other examples of 
research involving human subjects where human dignity was not maintained and observing that in 
medicine's quest to become a respected science, "doctors lost sight of the fact that it is one thing to 
experiment with atoms and molecules and quite another to do so with human beings"). 
5. Larry I. Palmer, Paying for Sujfering: The Problem of Human Experimentation, 56 Mo. L. 
REv. 604 (1997). 
6. See PUB. HEALTH SERV., U.S. DEP'T OF HEALTH, EDUC. & WELFARE, FINAL REPORT OF THE 
TUSKEGEE SYPHILIS STUDY AD HOC ADVISORY PANEL (1973) [hereinafter TUSKEGEE ADVISORY 
PANEL REPORT], available at http://biotech.law.lsu.edu/cphl/history/reports/tuskegee/tuskegee.htrn. 
7. Larry I Palmer, Disease Management and Liability in the Human Genome Era, 47 VILL. L. 
REv. 1 (2002). 
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The presence of Joe Goldstein and others signaled to me that our discourse 
with Anna Freud was part of a much wider conversation about the relationship 
between psychoanalysis and law, a topic Robert Burt elegantly addresses in his 
paper for this symposium. 8 More important, it signaled to me Jay's generosity 
and openness to ideas and colleagues. In the classroom discussion of Painter v. 
Bannister,9 Anna Freud outlined her rationale for defending the court's 
disposition of the child custody dispute in favor of the grandparents, i.e., the 
"psychological parent," over the child's biological father. As it turned out, what 
was going on during Anna Freud's visits to our class was the outlining of themes 
that she, Joe Goldstein, and Albert Solnit subsequently pursued in their Beyond 
the Best Interests of the Child. 10 Experiencing something rare and wonderful 
during that course stimulated me to work with my own students in such a way 
that the larger context of my scholarship could in tum inspire each student to find 
his or her light. 11 Thus, my first tribute to Jay is a personal note of gratitude: He 
has the ability to inspire those of us exposed to his light to take risks when we 
speak as citizens and as scholars. 12 
II. JAY'S INFLUENCE: TEACHING ETHICS 
When Alex Capron was editor of a special edition of the American Society 
of Law, Medicine and Ethics' journal honoring Jay's work, he asked me to 
contribute a piece, and I chose to write about how Jay's approach to human 
research could be a model for revitalizing interdisciplinary teaching. 13 At the 
time I was co-teaching a seminar for undergraduates on "Institutions and Social 
Responsibility" 14 in Cornell University's Biology and Society Program that used 
some materials from Jay's casebook on human experimentation. 15 In the course 
8. Robert Burt, The Uses of Psychoanalysis in Law: The Force of Jay Katz's Example, 6 
YALE J. HEALTH POL'Y L. & ETHICS 40 I (2006). 
9. 140 N.W.2d 152 (Iowa 1966). 
10. JOSEPH GOLDSTEIN ET AL., BEYOND THE BEST INTERESTS OF THE CHILD (2d ed. 1979); see 
also JOSEPH GOLDSTEIN ET AL., IN THE BEST INTERESTS OF THE CHILD ( 1986). 
II. Larry I. Palmer, Research with Human Subjects as a Paradigm in Teaching, 16 L. MED. & 
HEALTH CARE 183 (1988). 
12. Joe Goldstein's warning to psychoanalysts to distinguish between their roles as scientists 
and their roles as mere citizens should be heeded by bioethicists today, who regularly are called 
upon to provide normative answers to whether a particular line of research~ for instance, stem cell 
research on cloned embryos~should proceed. See Joseph Goldstein, Psychoanalysis and 
Jurisprudence, 77 YALE L.J. I 053, I 059-60 ( 1968). 
13. Palmer, supra note II. 
14. /d. at 183. 
15. KATZ ET AL., supra note I, at 9-65. 
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of writing my article during the summer of 1989, I took a morning away from my 
duties as a vice president at Cornell to go to the library. There I encountered 
David Feldshuh, the author of the play, Miss Evers' Boys, 16 a fictionalized 
account of the Tuskegee Study. 
As we stood in the library lobby conversing, David, a physician by training 
with a Ph.D. in theater arts, asked me: "Do you know anything about the 
Tuskegee Syphilis Study?" Inspired, perhaps, by the generosity toward the 
perspectives of other scholars I remembered from Jay's class, I tried to hear the 
anxiety or the silence behind David's question and recognized the invitation to 
conversation. I told him about the paper I was writing, about Jay's role on the 
Tuskegee Syphilis Study panel, and about how I had followed the developments 
regarding the Tuskegee Study since 1972.17 That conversation led David to ask 
me to read a draft of what would become Miss Evers' Boys before he took the 
play to the Sundance Festival. David was not concerned, as some critics were, 
with the politics of race and gender that might overshadow his attempts, as a 
white, male, Jewish physician-playwright, to portray the fictitious heroine of his 
play-an African-American public health nurse. Rather, he was concerned with 
his portrayal of the African-American physician. The implication-albeit a 
fictitious one-that Dr. Brodus, a black physician, was somehow involved in a 
study condemned as unethical and racist would raise some special issues. 18 The 
litigation on behalf of the survivors of the Tuskegee Study against the United 
States Government and the State of Alabama had alleged that the men were 
placed in the study without their consent solely because they were African-
Americans.19 
That conversation sparked several collaborations, including presentations of 
excerpts from the play before various audiences followed by interdisciplinary 
panel discussions about the issues of race, gender, and research raised by Miss 
Evers' Boys. The moving response of a large Cornell alumni audience to one of 
our panels convinced me to bring Miss Evers' Boys to Cornell as a way of 
engaging the entire campus in a conversation about research ethics, race, and 
gender. The 1991 theater production of Miss Evers' Boys at Cornell was a focal 
point of freshman orientation and became part of the eventual production of the 
prize-winning educational video, Susceptible to Kindness: 'Miss Evers' Boys' 
and the Tuskegee Syphilis Study.20 
16. DAVID FELDSHUH, MISS EVERS' BOYS ( 1995). 
17. Palmer, supra note 2, at 245. 
18. Palmer, supra note 5, at 614-16. 
19. /d. at 609. 
20. Videotape: Susceptible to Kindness: 'Miss Evers' Boys' and the Tuskegee Syphilis Study 
(Cornell Univ. 1994). 
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In writing the study guide to accompany the video, I was inspired again by 
Jay's approach to teaching and scholarship, in which framing the question is the 
key to analysis. Recall that each part of Jay's casebook starts with a narrative 
introduction that ends with four to six overarching questions. 21 These questions 
help both the teacher and the student organize the process of reflection and 
engaging discussion provoked by the 200 to 300 pages that follow each 
introduction. I thought our forty-two minute video, which included vignettes 
from the play, comments by "experts," interviews with survivors from the 
Tuskegee Study, and documentary material about the conditions in rural 
Alabama, needed a set of questions that would help teacher-leaders guide a 
reflective discussion of the issues raised by the various vignettes from the play. 22 
I organized the study guide around a major question for each of the six vignettes 
from the play. For instance, given Jay's analysis of the role of the Hippocratic 
Oath in the success or failure of physician-scientists in securing consent,23 I 
encouraged discussion leaders to ask, in relation to the nurse-scientist, Miss 
Evers, "[i]n a religiously diverse society, before whom should modem 
professionals take their oath?"24 While that question related to the first of the six 
vignettes, the same question is discussed by the expert commentators on the 
video. Furthermore, in designing the questions, I had to keep in mind that the 
leaders and students considering my questions would come from a variety of 
disciplines. 
Building from this interdisciplinary and collaborative work on the Tuskegee 
project, I began to develop a research agenda around two issues that are 
pervasive in research on human subjects. First, in my own writing about the 
issues of race and genetics, I have been inspired by Jay to develop a framework 
that will help us question some common assumptions about how to deal with 
increasingly diverse research subjects. Second, I have been drawn to consider 
what it means to be a "professional" in the field ofbioethics. 
III. PROFESSIONALISM, RACE, AND HUMAN SUBJECTS RESEARCH 
The Institute of Medicine and others have called for greater training m 
"cultural competency"25 on the part of health professionals in response to 
21. KATZ, supra note I, at 7, 8. 
22. See Larry !. Palmer, Writing Law, in WRITING AND REVISING THE DISCIPLINES 113, 121-23 
(Jonathan Monroe ed., 2002). 
23. JAY KATZ, THE SILENT WORLD OF DOCTOR AND PATIENT 93-94 (Johns Hopkins Univ. Press 
2002) ( 1984). 
24. LARRY !. PALMER, SUSCEPTIBLE TO KiNDNESS: MISS EVERS. 80I'S AND THE TUSKEGEE 
SYPHILIS STUDY: STUDY GUIDE FOR DISCUSSION LEADERS 9, II ( 1994 ). 
25. INST. OF MED., UNEQUAL TREATMENT: CONFRONTING RACIAL AND ETHNIC DISPARITIES IN 
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granting agencies' insistence that racial and ethnic minorities have "an equal 
opportunity" to participate in clinical trials. My concern is that we assume too 
easily that minority medical students, minority physicians, or minority outreach 
workers will not experience a cultural divide in seeking to recruit minority 
research subjects. Discussions of this topic often ignore the possibility that 
minority professionals may, in some cases, be committed primarily to the modem 
biomedical definition of "professional," thereby sharing with their non-minority 
colleagues tendencies toward silence in terms of sharing risks. 26 To put it another 
way, why should we believe that minority physicians will not concentrate as 
much as their majority counterparts on minimizing physical harm during 
interventions, while largely ignoring risks to the subject's sense of human 
dignity? Why do we assume that minority professionals will necessarily show 
greater respect for the authority of subjects to say "no" to participation in 
research?27 
When I listen to current discussions about the need to recruit minority 
members as organ donors, donors of tissue samples for genetic tests, or 
participants in clinical trials for diseases that disproportionately affect African-
Americans such as sickle-cell anemia, I often think back to the conflicted role of 
Dr. Brodus in Miss Evers' Boys. Dr. Brodus is the same race as the men involved 
in the Tuskegee study, but he is culturally different from them. He does not, for 
instance, understand much about the form of folk dance in which one of the men 
is deeply involved?8 He, like the white doctor in the play, Dr. Douglas, needs the 
black public health nurse, Miss Evers, to translate his medical terminology.29 Dr. 
Brodus questions Dr. Douglas's decision to start the study of untreated syphilis in 
the Negro male, but eventually acquiesces when Dr. Douglas suggests that a 
scientific study might prove that both races are biologically the same. 30 Dr. 
Brodus's fictionalized struggle illustrates that employing racially diverse medical 
professionals is not a quick fix for the problems raised by the vulnerability of 
minority subjects. What we need, rather, is for bioethicists of all racial and ethnic 
backgrounds to find a forum for having open discussions about racial and ethnic 
differences in the genomic era.31 Issues of race and ethnic status cannot be 
resolved by a procedural approach built on avoiding physical harms. Thinking 
about race in the post-Tuskegee world, where de jure segregation no longer 
HEALTHCARE 199-214 (2002) (encouraging medical educators to increase physician skills m 
cultural competence as a means of eliminating health disparities). 
26. KATZ, supra note 23, at 1-29. 
27. See Palmer, supra note 5, at 611-13. 
28. FELDSHUH, supra note 16, at 72-73. 
29. !d. at 72, 75-77. 
30. !d. at 39-44. 
31. Ari Patrinos, 'Race' and the Human Genome, 36 NATURE GENETICS S I (2004). 
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exists, requires us to embrace Jay's call for more attention to risks to human 
dignity in human research. 
IV. BIOETHICS AS A PROFESSION 
The second challenge we must face is that of the professionalization of 
bioethics itselr.J2 When Jay, the insider and the outsider, worked with Alex 
Capron and Eleanor Glass on their classic book on human experimentation,33 
they challenged scientists of all kinds, including social scientists, to examine the 
ethics of their work. Since the outset of the Human Genome Project, the ethical, 
legal, and social implications (ELSl) of genetic developments have become part 
of the federal research agenda. But the allocation of three to five percent of 
genetic research funds to ELSI work34 may be both a curse and a blessing. 
We, the bioethicists, now have a potential source of funding that equips us to 
convince university administrators to build centers for bioethics within 
universities. This institutionalization within the federal research funding structure 
may be seen as a positive sign that we can carry on the process of providing the 
critical analysis of research development. On the other hand, given the failures 
that Alex Capron outlines in his paper, 35 we ought to pay attention to the possible 
downsides of our marriage to federal funding. Given this dilemma, how do we 
avoid becoming captive to the ethos that scientific knowledge automatically leads 
to social progress? How many of us will have the courage that Jay demonstrated 
to dissent?36 Will we be able to challenge federal funding officials when the 
funding of our centers or programs is partially dependent upon our maintaining a 
certain kind of favorable visibility among program officers? 
I am not suggesting that any of these dangers has been realized in any 
particular ELSl project of which I am aware. I am, however, suggesting that it is 
our responsibility to start asking questions about our own role in relationship to 
the funding for our work, and to develop a research agenda that reflectively 
assesses and challenges our own relatively new profession. We should not make 
32. In Grimes v. Kennedy Krieger, 782 A.2d 807 (Md. 200 I), the court relied upon bioethics 
literature to hold that researchers could be civilly liable for an impaired informed consent process 
where parents were asked to consent, on behalf of their children, to participation in a lead-
abatement study involving low-income housing. See Larry I. Palmer, Genetic Health and Eugenics 
Precedents: A Voice of Caution, 30 FLA. ST. U. L. REV. 237,244-53 (2001 ). 
33. KATZ ET AL., supra note I. 
34. Human Genome Program, U.S. Dep't of Energy Office of Sci., Human Genome Project 
Information: Ethical, Legal, and Social Issues, http://www.oml.gov/sci/techresourees/Human_ 
Genome/elsi/elsi.shtml (last visited Apr. ll, 2006). 
35. Capron, supra note 3. 
36. Katz, Regulation, supra note 4. 
461 
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS VI:2 (2006) 
the fatal error of presuming that our own good intentions and so-called 
"expertise" in bioethics provide sufficient insurance against our participating in 
or enabling affronts to human dignity within the research process. 
Let me use an illustration from my own recent work as the principal 
investigator on a grant for teaching cultural competency in medical schools. My 
proposal involved a disease-based model for training in cultural competency and 
built on some work dealing with sickle cell anemia already being done at my 
current institution.37 When I was filling out the human subjects protection section 
of the grant proposal, I was tempted to state that there were minimal risks to the 
students and faculty involved in my "teaching experiment" because the physical 
risks were minimal. I was further tempted to admit only a risk of loss of 
confidentiality during the evaluation required by the request for proposals. 
Perhaps it was working on this paper that pushed me to venture beyond such 
boilerplate statements. Instead, I felt compelled to outline for the peer-review 
group the true risks to human dignity I could foresee even at this research design 
stage of the study. I proposed including in the consent form, in addition to the 
standard language about possible physical harms, some language about the risks 
of stigma and dignitary harms to both individuals and communities that might 
result from participation in a project that attempts to deal with race. 
For example, in the context of a training program meant to increase the 
"cultural competency" of future physicians, it is possible that some of the 
materials used, such as the educational video on the Tuskegee Syphilis Study, 
could provoke teachers and leaders to make statements that would make some 
individuals feel stereotyped and disrespected. This risk applies to both minority 
and non-minority students. Being labeled a "racist" has professional implications 
for a future physician of any race or ethnicity. On the other hand, a racial or 
ethnic minority student's learning might be hindered by provocative and 
insensitive statements by white students about supposed customs of Jews, 
Muslims, African immigrants, "Hispanics," or African-Americans. These risks 
are real and worthy of mention in the context of a training project because 
training is human experimentation. We should be aware of the dignitary risks 
involved in education, in attempting to shape people's minds as educators in a 
value-laden field such as ethics. Jay's approach to research with human subjects, 
~s I observed above, provides an excellent framework for analyzing the nature of 
teaching and education. If knowledge changes people, then those of us involved 
37. Kathy Keadle, Bridging the Gap, MEDICINE (Univ. of Louisville, Louisville, KY), 
Fall/Winter 2002, at 8, available at http://www.louisville.edu/hsc/medmag/fw02/sickle.html; 
Tiffani Humphrey et a!., The Medical Student Sickle Cell Project: Innovation, Outreach, 
Opportunities, Oral Presentation at the 32nd Annual Convention of the Sickle Cell Disease 
Association of America, Inc. (Sept. 30, 2004) (on file with author). 
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tn the transmission of knowledge to others are constantly involved in human 
experimentation. 
V. LESSONS FOR THE GENOMIC ERA 
I have shown how Katz's analysis of human experimentation has influenced 
my own thinking with respect to issues of race, ethics, and education. I would 
like to close with some thoughts about how his insights should influence all of 
our thinking in the near future. Specifically, I want to caution that Katz's 
fundamental insight-that we must always consider carefully the potential 
implications of our work for the dignity of human persons-will be crucial as we 
enter the genomic era. Genomic science has conclusively shown that we are 
biologically one race. 38 With such worldwide scientific consensus and the growth 
of the research enterprise, we should be careful not to overlook the persistent and 
growing risks associated with social, ethnic, and religious differences. Put 
another way, as scholars and citizens, we are at risk of failing to respect "the 
dignity of difference."39 Jonathan Sacks, a theologian, philosopher, and rabbi, 
insightfully describes the challenge of thinking about ethical discourse in a 
pluralistic society: "Plato's assertion of the universality of truth is valid when 
applied to science and a description of what is. It is invalid when applied to 
ethics, spirituality, and our sense of what ought to be."40 
Jay challenges us-particularly those of us trained as lawyers-to move 
beyond law's traditional focus on physical harms to subjects, to consider how 
risk-taking on the part of both subjects and investigators enhances or diminishes 
human dignity. 41 I would propose that in dealing with the issue of race in the 
genomic era, we must combine Jay's quest for individual human dignity within 
the research process with a new systemic or institutionalist perspective towards 
the dignity of racial, ethnic, and religious differences. Those of us mentored by 
Jay, as a teacher, scholar, and friend, are aware that the challenge to be faced 
involves not only protecting individuals, but also respecting-without 
stigmatizing-groups and developing analyses of the research process that 
facilitate that respect. 
Genomics, informational technology, and a global economy have 
dramatically changed our human environment since the publication of Jay's 
pioneering book on human experimentation. Alex Capron's work at the World 
38. Patrinos, supra note 31, at S I. 
39. JONATHAN SACKS. THE DIGNITY OF DIFFERENCE: HOW TO A VOID THE CLASH OF 
CiVILIZATIONS (2d ed. 2003). 
40. /d. at 54. 
41. Jay Katz, Statement of Committee Member Jay Katz, in ADVISORY COMM. ON HUMAN 
RADIATION EXPERIMENTS, THE HUMAN RADIATION EXPERIMENTS 543 ( 1996). 
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Health Organization demonstrates that the scope of our concern as bioethicists 
has expanded to encompass the globe and its varied peoples. What has not 
changed-and, in my view, should not-is our continuous effort to emulate the 
respect for every human being Jay modeled in his teaching, scholarship, and 
everyday encounters. 
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